|
|
|
|
| LEADER |
04310nmm a2200301 u 4500 |
| 001 |
EB000712838 |
| 003 |
EBX01000000000000000565920 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9789400950061
|
| 100 |
1 |
|
|a Gross, D.R.
|
| 245 |
0 |
0 |
|a Animal Models in Cardiovascular Research
|h Elektronische Ressource
|c by D.R. Gross
|
| 250 |
|
|
|a 1st ed. 1985
|
| 260 |
|
|
|a Dordrecht
|b Springer Netherlands
|c 1985, 1985
|
| 300 |
|
|
|a 630 p
|b online resource
|
| 505 |
0 |
|
|a 1: General Principles of Animal Selection, Pre- and Post-Operative Care, Preanesthesia, Chemical Restraint and Analgesia -- 1. Physical examination -- 2. Normal physiological parameters -- 3. Animal behavior considerations -- 4. Special requirement considerations -- 5. The use of anticholinergic drugs for preanesthesia -- 6. Preanesthetic agents -- 7. Recognition of pain and the use of analgesics -- 2: Cardiovascular Effects of the Opiods -- 1. Morphine -- 2. Meperidine -- 3. Methadone -- 4. Pentazocine -- 5. Fentanyl -- 6. Oxymorphone -- 7. Naloxone -- 8. Etorphine -- 9. Others -- 3: Cardiovascular Effects of the Tranquilizers -- 1. Phenothiazine derivatives -- 2. Butyrophenones -- 3. Benzodiazephines -- 4. Rauwolfia derivatives -- 5. Xylazine -- 4: Cardiovascular Effects of Other Drugs Commonly Used in Cardiovascular Research -- 1. Combinations -- 2. Neuromuscular blocking agents -- 3. Skeletal muscle relaxants -- 4. Non-steroidal anti-inflammatory and analgesic agents --
|
| 505 |
0 |
|
|a 2. Recording -- 3. Measuring electrical events -- 4. Measuring force and pressure events -- 5. Measuring interstitial fluid pressures -- 6. Measuring pressure in the micro-vasculature -- 7. Indirect techniques for measuring arterial pressures -- 8. Measuring flow events -- 9. Measuring chemical events -- 10. Measuring dimension changes -- 11. Measuring temperature changes -- 12. Calculation and/or measurement of volumes -- 13. Use of the microsphere technique for estimating tissue blood flows
|
| 505 |
0 |
|
|a 9: Normal Cardiovascular Parameters from Intact, Awake Animals -- 1. Dogs -- 2. Cats -- 3. Rats -- 4. Rabbits -- 5. Sheep -- 6. Calves -- 7. Pigs -- 8. Ponies -- 9. Primates -- 10: Naturally Occurring Models of Cardiovascular Disease -- 11: Iatrogenic Models for Studying Heart Disease -- 1. Heart failure models -- 2. Portal hypertension models -- 3. Isolated heart preparations -- 4. Microvascular studies -- 5. Organ culture -- 6. Streptococcal rheumatic carditis -- 12: Animal Models of Atherosclerosis -- 1. Quantification techniques -- 2. Pathogenesis -- 3. Natural occurrence -- 4. Specific animal models -- 5. Regression studies -- 13: Animal Models of Hypertension -- 1. Renovascular hypertension -- 2. Spontaneously hypertensive rats (SHR) -- 3. Dahl salt-sensitive rats -- 4. Salt and DOCA — salt models -- 5. Neurogenic hypertension and the central component -- 14: In-Vivo Measurements, Pitfalls and Problems of Instrumentation -- 1. Transduction of physiological events --
|
| 505 |
0 |
|
|a 5. Antibiotics -- to the Anesthetic Agents -- 5: Cardiovascular Effects of Intravenous Anesthetic Agents -- 1. Barbiturates -- 2. Alpha-chloralose -- 3. Urethane -- 4. Alpha-chloralose and urethane combined -- 6: Cardiovascular Effects of Inhalant Anesthetic Agents -- 1. Halothane -- 2. Enflurane -- 3. Methoxyflurane and Isoflurane -- 4. Diethyl ether -- 5. Nitrous oxide -- 6. Cyclopropane, Chloroform, Fluroxene and Trichlorethylene -- 7: Cardiovascular Effects of Halucinogens, Neurolept Analgesic/Anesthetic Combinations and Steroid Anesthetics -- 1. Ketamine -- 2. Ketamine-tranquilizer combinations -- 3. Tranquilizer — opiod combinations -- 4. Guaifenesin and the steroid anesthetics -- 8: Effects of Chemical Restraint and Anesthesia on Blood Glucose Levels -- 1. Opiods -- 2. Tranquilizers -- 3. Xylazine -- 4. Barbiturates -- 5. Urethane -- 6.Inhalent anesthesia -- 7. Neurolept analgesics/anesthetics -- 8. Droperidol and Fentanyl --
|
| 653 |
|
|
|a Cardiology
|
| 653 |
|
|
|a Veterinary Science
|
| 653 |
|
|
|a Veterinary medicine
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 028 |
5 |
0 |
|a 10.1007/978-94-009-5006-1
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-94-009-5006-1?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.12
|